Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Jeffrey A. RonaCbfo | Ovid TherapeuticsOVID | Open-market sale | 02/23 | 03/02 | 8,541 sh | $1.45 | $12,384.45 | −8.8% |
Margaret A. AlexanderPresident and CEO | Ovid TherapeuticsOVID | Open-market sale | 02/23 | 03/02 | 11,656 sh | $1.45 | $16,901.2 | −15.9% |
Jeffrey A. RonaCbfo | Ovid TherapeuticsOVID | Open-market sale | 25/02/26 | 25/02/28 | 3,902 sh | $0.56 | $2,185.12 | −5.4% |
Margaret A. AlexanderPresident and COO | Ovid TherapeuticsOVID | Open-market sale | 25/02/26 | 25/02/28 | 5,279 sh | $0.56 | $2,956.24 | −6.7% |
Margaret A. AlexanderPresident and COO | Ovid TherapeuticsOVID | Open-market buy | 25/01/27 | 25/01/29 | 6,810 sh | $0.73 | $4,971.3 | +24.2% |
Ovid TherapeuticsOVID | Open-market buy | 24/03/18 | 24/03/20 | 18,248 sh | $2.76 | $50,364.48 | +0.5% |